Bill Snyder
-
MRI technique detects spinal cord changes in MS patients: study
A Vanderbilt University Medical Center-led research team has shown that magnetic resonance imaging (MRI) can detect changes in resting-state spinal cord function in patients with multiple sclerosis (MS). Read MoreApr 19, 2018
-
Former FDA official explores big data’s impact on healthcare
“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week. Read MoreApr 19, 2018
-
Symposium to honor Robertson’s research contributions
David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium. Read MoreApr 19, 2018
-
Research lab honored by World Vaccine Congress
The laboratory of James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week. Read MoreApr 12, 2018
-
“Idling” cancer cells may return
Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment. Read MoreApr 11, 2018
-
Vanderbilt scientists test potential new way to treat anemia
Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells. Read MoreApr 10, 2018
-
Nashville Biosciences created to leverage wealth of data
Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development. Read MoreApr 5, 2018
-
Founders’ Celebration for Institute of Chemical Biology set for March 28
The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator. Read MoreMar 22, 2018
-
Study tracks protein’s role in stem cell function
MCL-1 is a member of the BCL-2 family of proteins important for blocking apoptosis, or programmed cell death. Many types of cancer cells escape the body’s effort to kill them by overexpressing MCL-1. Read MoreMar 22, 2018
-
Volunteers sought for bird flu vaccine trial
Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.” Read MoreMar 15, 2018
-
MIT’s Wittrup set for March 22 Flexner Discovery Lecture
K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22. Read MoreMar 15, 2018
-
Long QT syndrome – revealed
Vanderbilt investigators have used sophisticated cell biological and structural techniques to “classify” mutations in potassium channels, studies that could lead to personalized treatment of heart rhythm disorders. Read MoreMar 12, 2018
-
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D). Read MoreMar 6, 2018
-
Graphene material strengthens nerve signaling in the brain
Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery. Read MoreMar 1, 2018
-
Hope for an RSV vaccine
Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read MoreFeb 23, 2018
-
Brain Awareness events highlight mind’s wonders
Research on circadian rhythms, longevity and the brain’s pleasure system will be featured during this year’s Brain Awareness events sponsored by the Vanderbilt Brain Institute. Read MoreFeb 22, 2018
-
Vanderbilt’s Gamazon named visiting fellow at Cambridge University
Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows. Read MoreFeb 15, 2018
-
Noted neuroscientist Gouaux set for Discovery Lecture
Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22. Read MoreFeb 15, 2018
-
Event showcases REDCap’s data management versatility
Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe. Read MoreFeb 8, 2018
-
Study helps map signaling system in brain linked to ASD
Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD). Read MoreFeb 8, 2018